PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514910
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514910
Percutaneous Nephrolithotomy System Market size was valued at USD 18,255.45 million in 2023, expanding at a CAGR of 7.6% from 2024 to 2032.
Percutaneous nephrolithotomy is a surgical technique employed to extract kidney stones from the body when they are unable to pass naturally. This procedure is usually suggested for sizable or intricate stones that cannot be adequately treated using less invasive approaches like shock wave lithotripsy or ureteroscopy. PCNL continues to be a crucial choice in the urologist's arsenal for managing complex renal stones, as it combines state-of-the-art technology with proficient surgical techniques to deliver efficient patient care.
Percutaneous Nephrolithotomy System Market- Market Dynamics
The increasing incidence of kidney stones on a global scale is expected to propel market expansion.
Kidney stones are on the rise globally, impacting individuals of all age groups and backgrounds. PCNL, a highly efficient technique for eliminating large or intricate kidney stones, offers patients relief from symptoms and reduces the likelihood of complications associated with untreated stones. In the United States alone, kidney stone disease affects approximately 1 in every 500 individuals annually. According to the University of Florida Health, this disease will develop in 1 out of 8 men (with the highest incidence occurring between 40-60 years) and 1 out of 16 women (with the highest incidence between 20-50 years) over their lifetime. Moreover, continuous advancements in PCNL systems, such as improved imaging technology, lithotripsy devices, and miniaturized instruments, present opportunities for market expansion. However, the high cost associated with PCNL procedures may impede the growth of the market.
Percutaneous Nephrolithotomy System Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.6% over the forecast period (2024-2032)
Based on product type segmentation, Mini Percutaneous Nephrolithotomy was predicted to show maximum market share in the year 2023
Based on application segmentation, Clinics was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Percutaneous Nephrolithotomy System Market is segmented based on Product Type, Application, End-User, technology, and Region.
The market is divided into three categories based on product type: Micro-Percutaneous Nephrolithotomy, Ultra-Mini Percutaneous Nephrolithotomy, and Mini-Percutaneous Nephrolithotomy. Mini Percutaneous Nephrolithotomy dominates the market. Mini-PCNL techniques are increasingly adopted by urologists worldwide due to their potential advantages, such as reduced postoperative pain, shorter hospital stays, and faster recovery times compared to traditional PCNL. This has contributed to the overall growth of the PCNL system market.
The market is divided into two categories based on application: Hospitals, Ambulatory Surgical Centers, and Clinics. Clinics dominate the market. Clinics play a crucial role in providing comprehensive care to patients undergoing PCNL procedures, including preoperative counseling, perioperative management, and follow-up care to monitor recovery and address any complications.
The market is divided into two categories based on End-User: Adults and Pediatrics. The PCNL system market serves both adult and pediatric end-users, each with distinct demographic characteristics, clinical considerations, and market dynamics.
The market is divided into two categories based on Technology: Digital and manual. The PCNL system market encompasses a diverse range of digital and manual technologies, each playing a vital role in optimizing procedural outcomes, enhancing patient safety, and facilitating the delivery of high-quality care in kidney stone management.
Percutaneous Nephrolithotomy System Market- Geographical Insights
Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market is predominantly dominated by North America, primarily due to the expansion of healthcare infrastructure and the increasing preference for minimally invasive surgical procedures. North America takes pride in its well-established healthcare infrastructure, which includes advanced medical facilities such as hospitals, clinics, and ambulatory surgical centers equipped with state-of-the-art technology. The growing focus on patient satisfaction and quality of life has led to a higher demand for minimally invasive treatment options like PCNL among patients with kidney stones. The American Society of Plastic Surgeons (ASPS), the largest plastic surgery organization in the world, represents 92 percent of all board-certified plastic surgeons in the United States. According to their data, there were 26.2 million surgical and minimally invasive cosmetic and reconstructive procedures performed in the United States in 2022. Specifically, there has been a 19% increase in cosmetic surgery procedures since 2019. Europe holds the second-largest region for market growth, mainly due to the growing emphasis on patient-centered care and personalized treatment approaches.
Manufacturers in the industry focus on research and development to introduce new technologies and product enhancements, such as compact instruments for Mini-PCNL, advanced imaging solutions, and integrated navigation systems. Competitors differentiate themselves by offering a wide range of products tailored to all stages of PCNL procedures, from initial access and visualization to stone fragmentation and extraction, designed to meet diverse clinical needs. Companies aim to expand their presence in the global market by establishing strategic partnerships, distribution agreements, and acquisitions to capitalize on emerging opportunities and strengthen their competitive edge.
In February 2024, KARL STORZ United States has recently entered into an exclusive partnership with Well Lead Medical to provide the ClearPetrasuction-evacuation ureteral access sheath. This collaboration aims to enhance the effectiveness of KARL STORZ endoscopic visualization devices in the field of comprehensive urinary stone management.
GLOBAL PERCUTANEOUS NEPHROLITHOTOMY SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Karl Storz
PolyDiagnost
InnoMedicus
Electro Medical Systems
Olympus
Cook Medical
Boston Scientific
Others